Exclusive

Publication

Byline

Takeda, OrigiMed to develop genomic based clinical treatment platform

OrigiMed, a China, Nov. 12 -- based leading precision medicine company, and Takeda, a global biopharmaceutical company based in Japan have announced their strategic partnership to develop a genomic-ba... Read More


QIAGEN launches portable digital SARS-CoV-2 Ag test

Singapore, Nov. 12 -- QIAGEN has recently started commercialization of a portable digital test in the United States that can be used by laboratories to detect SARS-CoV-2 antigens in people with active... Read More


Insilico announces AI-powered drug discovery collaboration with Janssen

Hong Kong, Nov. 11 -- based Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, has announ... Read More


KT Corp to expand digital health business

Singapore, Nov. 11 -- KT Corporation, South Korea's largest telecommunications company, is diversifying its business from robotics to digital health as part of efforts to develop new growth engines in... Read More


Certara opens new office in Shanghai

Singapore, Nov. 11 -- Certara, a global leader in biosimulation, recently announced the opening of a new office in Shanghai's Pudong District, China's epicentre for biopharmaceutical research and deve... Read More


Holmusk partners with Merck to focus on diabetes & prediabetes patients in APAC

Singapore, Nov. 11 -- based Holmusk has announced a collaboration with the healthcare business sector of Merck, to support patients and physicians in Asia-Pacific (APAC) with a holistic treatment appr... Read More


Fujitsu, TMDU leverage world's fastest supercomputer to perform cancer gene network analysis

Singapore, Nov. 10 -- Tokyo Medical and Dental University (TMDU) and Fujitsu Laboratories Limited have recently completed, in less than a day, an estimation of the network that represents the influenc... Read More


COVID-19 vaccine candidate by Pfizer, BioNTech shows more than 90% effectivity

Singapore, Nov. 10 -- Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants... Read More


Olympus brings procedure kits into endotherapy portfolio

Japan, Nov. 10 -- based Olympus has recently announced the launch of the Olympus Procedure Kits, in partnership with US-based Ruhof Corporation, and Hybrid Tubing, two new single-use and single-day de... Read More


Australia invests $2.5M to ensure COVID-19 support for elders

Singapore, Nov. 10 -- The Australian government is ensuring senior Australians get the services and assistance they need with a $2.5 million investment to extend and expand the Older Persons COVID-19 ... Read More